Long-term blood thinners for left ventricular thrombus
Part of Heart & circulation clinical trials.
This study tests if taking blood thinners for a longer time improves outcomes for people with a blood clot in the left lower heart chamber. It helps doctors decide the best treatment duration to prevent complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a blood clot in the left lower heart chamber (left ventricular thrombus) on an echocardiogram.
- You are 18 years or older.
- You have no allergy to blood thinners and no medical reason that prevents you from taking them.
- You have not had surgery to remove the clot, heart transplant, valve replacement, or other heart procedures.
- You do not have other conditions requiring long-term blood thinners (like atrial fibrillation or mechanical heart valves).
- You are not pregnant, breastfeeding, and do not have severe liver, kidney, or blood problems, cancer, or a life expectancy under 3 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different ways of using blood thinners during procedures to fix a leaky mitral valve or close the left atrial appendage. The goal is to find the safest approach to prevent strokes and bleeding.
This study looks at whether taking blood thinners for a shorter or longer time is better for people with a blood clot in the heart. It will help doctors decide the right treatment duration to prevent serious complications.
This trial compares the blood thinner apixaban to warfarin for treating blood clots in the main pumping chamber of the heart (left ventricle). The goal is to see which medicine is better at preventing strokes and other complications.
This study looks at people age 18+ who were found to have a blood clot in the left side of the heart (left ventricular thrombus) on scans between 2013 and 2020. It will compare how different blood-thinner medicines were used and what outcomes occurred.
This trial tests how to use a blood thinner in people after a recent heart attack who have a clot in the left heart chamber confirmed by heart MRI. It may help lower the risk of the clot causing serious complications, but it also requires careful bleeding-safety screening.
This trial tests whether a newer blood thinner, apixaban, works better than the standard warfarin for treating blood clots in the left ventricle after a heart attack. The goal is to see which medication is safer and more effective at preventing complications.
Hear when a new Embolism and Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.